Association of the Promoter Methylation of Mitochondrial Transcription Factor A With Susceptibility to Metabolic Syndrome
Author | Mohammad Hashemi | en |
Author | Hamzeh Rezaei | en |
Author | Mahmoud Ali Kaykhaei | en |
Author | Mohsen Taheri | en |
Orcid | Mohammad Hashemi [0000-0002-6074-7101] | en |
Issued Date | 2014-04-01 | en |
Abstract | Background: It has been proposed that the patients with mitochondrial diseases usually manifest systemic metabolic disorders. The metabolic syndrome (MeS), a cluster of several metabolic disorders, is increasingly being recognized as a risk factor for type 2 diabetes (T2D) and cardiovascular disease. Objectives: The aim of study was to investigate the possible association between promoter methylation of mitochondrial transcription factor A (TFAM) and MeS. Patients and Methods: DNA was extracted from peripheral blood of 151 patients with and 149 without MeS. Results: TFAM promoter methylation was evaluated by a nested methylation-specific PCR (nested MSP). Conclusions: No association was found between TFAM promoter methylation and MeS. The present study suggests that the TFAM promoter methylation is not associated with risk of MeS. | en |
DOI | https://doi.org/10.17795/gct-18308 | en |
Keyword | Metabolic Syndrome X | en |
Keyword | Mitochondrial Transcription Factor A | en |
Keyword | Diabetes Mellitus | en |
Keyword | Type 2 DM | en |
Publisher | Brieflands | en |
Title | Association of the Promoter Methylation of Mitochondrial Transcription Factor A With Susceptibility to Metabolic Syndrome | en |
Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 15122-pdf.pdf
- Size:
- 109.65 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF